Business

Bausch + Lomb Announces Two Board of Directors Appointments

VAUGHAN, Ontario, December 17, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Eduardo C. Alfonso, MD, and Steven H. Collis have been appointed to its board of directors. The appointments are effective Jan. 1, 2026, and following changes announced in August 2025 the board will be comprised of 10 directors.

articleBausch + Lomb CorporationDecember 17, 20253/company/bausch-lomb-corp/news/bausch-lomb-announces-two-board-213000268
Bausch + Lomb Announces Two Board of Directors Appointments

About this update from Bausch + Lomb Corporation

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4152,"height":327,"url":"https://media.zenfs.com/en/business-wire.com/cf439db2cd49da1a96c3a1645a67f36d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8WCEsYTRvrpc50LdUCia8w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTc2O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/cf439db2cd49da1a96c3a1645a67f36d","width":960,"height":76},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/px2uQ83qpJ2pESzuwcatVw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xOTA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/cf439db2cd49da1a96c3a1645a67f36d","width":1200,"height":95}},"lazy":false},{"type":"text","content":"VAUGHAN, Ontario, December 17, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Eduardo C. Alfonso, MD, and Steven H. Collis have been appointed to its board of directors. The appointments are effective Jan. 1, 2026, and following changes announced in August 2025 the board will be comprised of 10 directors.","length":438,"tagName":"p"},{"type":"text","content":""Eddie is one of the most prominent and respected ophthalmologists in the world, and Steve delivered tremendous financial growth as the longtime CEO of a Fortune 10 company," said Brent Saunders, chairman and CEO, Bausch + Lomb. "With decades of hard-earned insight, they will help shape the future of Bausch + Lomb as we accelerate our strategy and pursue the significant opportunities ahead."","length":414,"tagName":"p"},{"type":"text","content":"About Eduardo C. AlfonsoEduardo C. Alfonso, MD, is an ophthalmologist and internationally recognized expert in corneal and external eye diseases. He serves as director of the Bascom Palmer Eye Institute and chair of the Department of Ophthalmology at the University of Miami Miller School of Medicine and holds the Kathleen and Stanley J. Glaser Chair in Ophthalmology.","length":370,"tagName":"p"},{"type":"text","content":"Dr. Alfonso earned his bachelor’s degree and medical degree from Yale University. He completed his ophthalmology residency at the Bascom Palmer Eye Institute, followed by advanced fellowships at Harvard Medical School in cornea, external d...

More updates from Bausch + Lomb Corporation

Bascom Palmer Eye InstituteEduardo C. AlfonsoSteven H. CollisBauschophthalmology residencyinternational ophthalmologyeye diseaseskeratoprosthesis